We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
Cap. Flow
+$802M
Cap. Flow %
0.75%
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$78.7M
2
XYZ
Block Inc
XYZ
+$49.3M
3
V icon
Visa
V
+$46.1M
4
AAPL icon
Apple
AAPL
+$45.4M
5
DASH icon
DoorDash
DASH
+$45.1M

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Financials 14.43%
3 Healthcare 10.97%
4 Consumer Discretionary 10.82%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPYPM
3551
Brookfield Property Partners 6.25% Class A Cumulative Redeemable Preferred Units Series 1
BPYPM
$1.78K ﹤0.01%
125
TECX
3552
Tectonic Therapeutic
TECX
$585M
$1.77K ﹤0.01%
100
CUK
3553
DELISTED
Carnival PLC
CUK
$1.75K ﹤0.01%
100
NVNO
3554
enVVeno Medical
NVNO
$7.08M
$1.64K ﹤0.01%
18
JG
3555
Aurora Mobile
JG
$29.8M
$1.6K ﹤0.01%
150
-3,164
-95% -$30K
NCNA
3556
NuCana
NCNA
$6.12M
$1.59K ﹤0.01%
9
+2
+29% +$396
ZEPP
3557
Zepp Health
ZEPP
$69.7M
$1.56K ﹤0.01%
529
-3,457
-87% -$10.3K
BLCO icon
3558
Bausch + Lomb
BLCO
$5.99B
$1.55K ﹤0.01%
107
-23
-18% -$378
PDLI
3559
DELISTED
PDL BioPharma, Inc.
PDLI
$1.51K ﹤0.01%
612
KZIA
3560
Kazia Therapeutics
KZIA
$159M
$1.49K ﹤0.01%
382
-174
-31% -$1.03K
AIXI
3561
Xiao-I
AIXI
$1.03M
$1.48K ﹤0.01%
18
JFU
3562
9F Inc
JFU
$29.1M
$1.41K ﹤0.01%
1,021
-2,748
-73% -$4.11K
BODI icon
3563
The Beachbody Company
BODI
$74.8M
$1.4K ﹤0.01%
187
CSIQ icon
3564
Canadian Solar
CSIQ
$1.08B
$1.39K ﹤0.01%
161
SII
3565
Sprott
SII
$3.03B
$1.39K ﹤0.01%
31
DTIL icon
3566
Precision BioSciences
DTIL
$207M
$1.31K ﹤0.01%
275
CNTB
3567
Connect Biopharma Holdings
CNTB
$139M
$1.3K ﹤0.01%
2,370
-7,130
-75% -$6.61K
HERE
3568
Here Group Ltd
HERE
$103M
$1.27K ﹤0.01%
317
-2,025
-86% -$4.98K
UXIN
3569
Uxin Ltd
UXIN
$282M
$1.23K ﹤0.01%
308
+50
+19% +$219
XIN
3570
DELISTED
Xinyuan Real Estate
XIN
$1.21K ﹤0.01%
470
MHH icon
3571
Mastech Digital
MHH
$93.1M
$1.2K ﹤0.01%
118
CNF
3572
CNFinance Holdings
CNF
$37.3M
$1.2K ﹤0.01%
154
-982
-86% -$10.5K
IPHA
3573
Innate Pharma
IPHA
$162M
$1.2K ﹤0.01%
675
CCM
3574
Concord Medical Services
CCM
$19.7M
$1.18K ﹤0.01%
295
-2,165
-88% -$10.1K
VALN
3575
Valneva
VALN
$541M
$1.17K ﹤0.01%
+174
New +$1.09K

Similar funds

RhumbLine Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
  • RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
  • RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
  • RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
  • RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
  • RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
  • RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.